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OBJECTIVES: A number of studies suggest that weight-bearing exercises have ben-
eficial effects on bone and increases in BMD of the skeleton. In Hungary 900,000
people suffer from OP, there are 30,000 vertebral fractures, 51,000 other fractures in
a year. The aim of this study was to measure if there is any direct, detected effect of
one specific physiotherapy programme on biomechanical markers of bone
metabolism.METHODS: Total of 50 young, healthy adults (age 252) were included
without any disease or condition of the calcium and bone metabolism (using lab-
oratory tests and Quantitative Ultrasound). Fifteen men and 15 women carried out
specific exercises during 60 min, directed by physiotherapist; and 20 women per-
formed 60 min steady walking in the same time. At the beginning and in the end of
training programs laboratory tests were carried out to measure the level of bone-
specific alkaline phosphate (BALP) and -cross-laps value. Data were analysed by
Wilcoxon tests applying SPSS statistic programme. RESULTS: In both groups a
slight, statistically not significant decrease was detected in the value of BALP
(p0.322 vs. p 0.219; rate of decrease in the target group 3.67%, in control group:
7.16%). Significant decrease was detected in the -cross laps-values in all groups. In
the target group the value of -cross laps decreased with 23.13% (p0.0066), in the
control group with 53.2% (p0.0008). No relationship was found between smoking,
rheumatic diseases run in the family and BMD, but a medium relationship between
regular exercise and BMD could be detected (r0.4392). CONCLUSIONS: This study
proved that the 60-minute, middle intensity, appropriate physiotherapy (even one-
time) has an immediate effect on BALP level, in contrary -cross-laps scores de-
crease significantly measured immediately after the training. So bone loss and at
the same time bone formation started due to mechanical overload.
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OBJECTIVES: Following the introduction of biologic DMARDs, clinicians have now a
multitude of options for the treatment of RA patients with inadequate response to
anti-TNF. This study considers evidence on ACR response from randomised con-
trolled trials of biologic treatments and employs a network meta-analysis to iden-
tify differences amongst them. METHODS: The study considers evidence for the
following treatments: abatacept, anti-TNF, rituximab, and tocilizumab. Pivotal
studies were reviewed and ACR response was extracted for each of the above
treatments. A network meta-analysis using a Bayesian approach was implemented
in WinBUGS®. Fixed-effects and random effects models were explored. Initially,
the development of the study considered all anti-TNF treatments separately.
However, there was limited evidence on ACR response for all of them in the spec-
ified patient subgroup (TNF-IR). This was considered an important factor for treat-
ment efficacy since studies performed on DMARD-IR or MTX-IR population would
include a subgroup of patients with less severe disease. A class effect was assumed
for all anti-TNF and ACR response from Smolen et. al (2009) was assumed to
represent treatment efficacy of all anti-TNFs. RESULTS: For the base-case analysis,
the result shows tocilizumab to have a significant benefit on ACR 20 response of
patients. In ACR 50 all biologics have a similar profile. Rituximab becomes the most
efficacious treatment in ACR 70. CONCLUSIONS: The study demonstrates that as-
suming an indirect comparison of biologics based on a network analysis, tocili-
zumab has better profile than the other biologics in ACR 20 and ACR 50 while
rituximab is better in ACR 70. Further research is needed to produce evidence on
ACR response for all treatments in TNF-IR population.
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OBJECTIVES: This study aims to investigate the major osteoporotic fractures inci-
dence in Taiwan from 2006 to 2009. METHODS: Using the inpatient and outpatient
database of the National Health Insurance. Elderly Women (50-100 years) who had
primary and secondary diagnosis of hip fracture (ICD9 code 820, 733.14), vertebral
fracture (ICD9 code 805, 806, 733.13), wrist fracture (ICD9 code 813, 733.12), and
other fracture (ICD9 code 807, 808, 810, 811, 812, 821, 823, 733.10, 733.11, 733.15,
733.16, 733.19) were identified and included in the study. Frequencies and inci-
dences of each fracture by age were estimated, and the 4-year incidence trend was
further evaluated. RESULTS:A total of 65,118 hip fractures, the most serious osteo-
porosis outcome, occurred during the study period and the incidence is increasing
by 3-6% per year. We found a high annual incidence rate of clinical vertebral frac-
ture in 4 consecutive years in Taiwan. The average rate was 1.43%, 1.51%, 1.59%,
and 1.63% respectively. In addition, Wrist fracture and other fracture all increased
slightly. Each type of fractures showed a steady increase in the age-adjusted
incidence. CONCLUSIONS: The age-specific incidence rates of hip fractures and
vertebral fractures were higher with increasing age, especially after 60 years of age.
Compared with other countries, Elderly Taiwanese women also have a high inci-
dence rate of hip and vertebral fracture. Our results clearly demonstrated that the
effect of osteoporosis and osteoporotic fracture in Taiwan. We should take more
active public health strategies in the rapidly aging society.
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OBJECTIVES: Low bone mineral density (BMD) is one of several important clinical
risk factors (CRFs) for fractures. However, frequency distributions of individual and
multiple CRFs have not been extensively reported. The study aim was to quantify
the CRF profile in a Canadian population. METHODS: Data on CRFs were obtained
from the Canadian Multicentre Osteoporosis Study (CaMos) database, a prospec-
tive and longitudinal cohort study following subjects for over10 years. Subjects
with femoral neck BMD T-scores  1.0 were selected and grouped as osteopenia
(1.0  T-score2.5), osteoporosis [OP] (T-score  2.5), very-low BMD [VLBMD]
(3.5  T-score 2.5), and extremely-low BMD [ELBMD] (T-score  3.5). Fre-
quencies of other CRFs (prevalent fracture, rheumatoid arthritis, glucocorticoid
use, parental hip fracture, smoking status, alcohol consumption, recent falls) were
estimated for BMD T-scores, by age and sex. RESULTS: Among low-BMD women,
2716 (85%) had osteopenia, 491 (15%) had OP; 460 and 31 had VLBMD and ELBMD,
respectively. There were 635 low-BMD men (602, 33, 30, and 3 with osteopenia, OP,
VLBMD, and ELBMD, respectively). OP prevalence increased by age in women
(men): 4% (9%) in age 50-59 to 43% (44%) in age 70-79. In OP women, 21% had 1
previous fracture; 10% had 2. Corresponding values for ELBMD women were 32%
and 52%, respectively. The distribution of multiple CRFs among OP women was:
35%, 43%, 17%, 4%, and 1% for 0-4 additional CRFs. None had over four. In OP
women with prevalent fracture, the distribution was 65%, 29%, 6%, and 1% for 1-4
additional CRFs. CONCLUSIONS:Among the low-BMD population in CaMos, 15% of
women and 5% of men had OP, and over 30% also had prevalent fracture. Over 50%
with OP and prevalent fracture also had at least one additional CRF. These data may
inform estimates on potential fracture incidence and burden in the population.
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OBJECTIVES: To estimate the prevalence of shoulder osteoarthritis (OA) and its
treatments. METHODS: Data from Thomson MarketScan (2005-2008), a large na-
tional managed care population database representing more than 500 million em-
ployer-based medical and pharmacy claims were analyzed. Annual prevalence was
calculated as the number of continuously eligible patients who had at least one
shoulder OA diagnosis divided by the total number of continuously eligible pa-
tients. Treatment prevalence was assessed for inpatient shoulder surgery, steroid
injections, physical therapy and pain medication and was calculated as the num-
ber of patients receiving these treatment divided by the number of patients with a
shoulder OA diagnosis. Prevalence percentages were presented descriptively by
age group and overall. RESULTS: There were approximately 20 to 26 million con-
tinuously eligible patients in the data annually between 2005 and 2008. The overall
prevalence of patients with at least one shoulder OA diagnosis was relatively stable
over the years and ranged from 1.1 to 1.2%. In 2008, the shoulder OA prevalence by
age group was: 0 to 18 – 0.01%; 18 to 40 – 0.21%; 40 to 65 – 1.55%; and 65 and
greater – 4.16%. Shoulder surgery was most prevalent in the 40 to 65 age group
(1%), with around 2% prevalence in the 65 and greater age group. Physical therapy
was most common in the 65 year old groups (16.2% to 14.8%), while 65 and older
age group had around 8% prevalence. Steroid injections occurred in 10% of the
patients who were 18 or greater. Use of pain medications increased with age and
ranged by age group from 5% to 36%. CONCLUSIONS: The prevalence of a shoul-
der OA diagnosis was approximately 1.1%, with patients 65 age having the high-
est prevalence (4%). Shoulder OA treatment related resource utilization showed
significant use of drug therapy, physical therapy, and steroid use.
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OBJECTIVES: The aim of the study is to evaluate the risk factors of second hip and
femur fractures in patients aged over 60 years after initial hip fractures.METHODS:
In this retrospective study the data derive from the financial database of the Hun-
garian National Health Insurance Fund Administration. The study includes pa-
tients over 60 years following primary treatment of femoral neck fracture (S7200)
discharged from inpatient care institutions in 2000. Fractures that happened in
hospitals were excluded from the analysis. The follow up period was 8 years. We
evaluated data according to sex, age group, type of living place, type of hospital
treated the primary fracture, type of primary femoral neck fracture, absence or
presence of comorbidities, type of surgical intervention for primary fracture, and
antiosteoporotic pharmacologic treatment after primary fracture. The effects of
prognostic factors were evaluated by Cox proportional hazard regression analysis
(HR, 95 % CI, p). RESULTS: Altogether 3638 patients were included into the study.
During the observation period 323 second hip fracture (8,87 %) were identified. The
following predictors (hazard ratios and p values) are listed: Sex (female/male):
1.516(0.010); Age group (70-79/60-69y): 1.350(0.058); (80-89/60-69y): 1.496(0.020);
(90y-/60-69y): 1.666(0.067); Residency (capital/village): 1.445(0.072); (city/village):
1.022(0.888); (big city/village): 1.238(0.219); Hospital (capital/county): 0.970(0.878);
(city/county): 1.228(0.156); (clinic/county): 1.105(0.598); Fracture type (lateral/dis-
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